ADHD in the News 2022-12-08

How to get through the U.S.’s Adderall shortage, according to a psychiatrist

A nationwide Adderall shortage has affected people with attention-deficit hyperactivity disorder since October, and it isn't expected to end until the new year. We spoke to a psychiatrist about the factors driving the shortage and tips for getting through it.

Young man’s death leads to questions about an Adderall prescription obtained online

Elijah Hanson struggled with his mental health for years. The 21-year-old from Tacoma, Washington, had been diagnosed with antisocial personality disorder and was receiving treatment from a local behavioral health clinic. According to years of therapy notes, he was desperate to better understand himself and his emotions.

Genetic vulnerability to ADHD signals risk of Alzheimer’s disease in old age

Genetic predisposition to attention-deficit/hyperactivity disorder (ADHD) can predict cognitive decline and Alzheimer's disease later in life, revealed an analysis published today in Molecular Psychiatry by University of Pittsburgh School of Medicine researchers.

How white matter affects ADHD symptoms in children

MRI studies have associated white matter bundles with greater severity of ADHD symptoms.

Study suggests the youngest children in class are being overmedicated for ADHD

Christine Strand Bachmann has led a study that includes all Norwegian children born between 1989 and 1998, a total of 488,000 people. The NTNU Ph.D. candidate has reviewed all the prescriptions the children received from the age of 10 until they were 23. She compared children born in January or February with those born in November or December.

Study suggests mind-wandering is an underlying dysfunction among children with ADHD

A study published in Research on Child and Adolescent Psychopathology explored the consequences of mind-wandering for children diagnosed with ADHD in medicated and unmedicated conditions. The study concludes that unmedicated children diagnosed with ADHD are more vulnerable to mind-wandering, resulting in off-task behavior.

ADHD patients may have lower functional connectivity in certain brain regions, study finds

An analysis of data from five large-scale studies found somewhat lower white matter fractional anisotropy in certain regions of the brain in persons diagnosed with attention deficit hyperactivity disorder (ADHD). Fractional anisotropy is generally considered an indicator of connectivity in the brain. Similar microstructural anomalies were not present for anxiety, mood, or externalizing problems. The study was published in Biological Psychiatry.

What It’s Really Like To Parent When You Have ADHD

Raising children while managing ADHD comes with a unique set of challenges on top of the usual difficulties of parenthood.

Role of Shared Decision Making in Treating Pediatric ADHD

Robert L. Findling, MD, MBA, and Timothy Wilens, MD, share their thoughts on treatment considerations with the patient’s family in pediatric ADHD.

ADHD in Therapists: How ADHD can affect those who treat it.

KEY POINTS: ADHD can show up in unique ways in therapists, both as challenges and strengths. ADHD can impact focus, organization, and various therapeutic skills. ADHD can also make for creative problem-solving and increased connection to emotions.

Why ADHD diagnoses have skyrocketed

The rate of ADHD diagnoses has been rising in the U.S. for the past two decades, and experts suspect that social media and the pandemic may be a catalyst. More Americans are seeking out treatment, which is straining the health care system. Then, in October, the Centers for Disease Control and Prevention announced there was a shortage of Adderall, both the brand and generic form. Watch the video above to learn more about ADHD and whether the medical system can handle the sharp rise in demand.

Risk of accidents and unintentional injuries in men and women with ADHD

Key Takeaways: Attention-deficit/hypersensitivity disorder (ADHD) has a lifelong increased risk of accidents; the risk is decreased in patients who are prescribed psycholeptics and stimulants.